Janssen’s erdafitinib is being analysed in Phase II and III clinical trials in advanced urothelial carcinoma patients. Credit: Michael Vi/Shutterstock.com. The Janssen Pharmaceutical Companies of
This piece was adapted from a recent First Opinion newsletter. Sign up to receive the First Opinion newsletter every Sunday. Recently, I made an appeal
Specialised Therapeutics signed an agreement with CanariaBio for licensing oregovomab. Credit: Specialised Therapeutics. Specialised Therapeutics (ST) has entered an exclusive agreement to license Korea-based CanariaBio’s oregovomab for